EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer

Study limitation reported by the research below: “Cost and reimbursement considerations are explicitly excluded from the recommendations, which may limit direct applicability in resource-constrained settings.”